Envoy Medical (COCH) announced the appointment of Michael Crowe to the Envoy Medical Board of Directors effective June 7, 2024. Envoy Medical is currently sponsoring an Early Feasibility Study at Mayo Clinic in Rochester, Minnesota for its investigational fully implanted Acclaim Cochlear Implant. Envoy Medical expects to begin a larger pivotal clinical study for its device later in 2024. Crowe is currently the Senior Vice President of Operations for Bioventus (BVS). Mr. Crowe will qualify as an Independent Director and serve on the Compensation Committee.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COCH:
- Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling
- Envoy Medical Announces Inclusion in the MSCI USA Micro Cap Index
- Envoy Medical announces inclusion in the MSCI USA Micro Cap Index
- Newly Published Peer-Reviewed Article Highlights Advances in Fully Implanted Cochlear Implant Technology
- Envoy Medical published article on fully implanted cochlear implants